No such message found

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My take on all this (IMO)

It is sort of a catch-22.  Yes, we are a real company but unfortunately the institutions of which you speak cannot take any positions because of our share price and exchange.  And although we have had several "watershed" developments occur in the last two years, here we are at .40.

If, and I am not necessarily espousing it, there were to be a reverse split, so that the stock could then qualify for Nasdaq, and subsequently then the institutions of which you speak could indeed take their positions, would we then not see the share price appreciate?

I do not know the answer or the best way to get us to the promised land; hopefully the investment bankers that the board alluded to in their letter last month will be able to offer the guidance necessary to enhance shareholder value....one way or another.

 

Share
New Message
Please login to post a reply